Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Czepulkowski

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Bone Marrow Transplantation|January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemiaJ Mehta, A Mijović, R Powles, et al.
Journal of Clinical Pathology|June 1, 1987
Unusual myeloid leukaemia in patient with Hodgkin's diseaseM A Horton, M J Barnett, L Goff, et al.
The British Journal of Dermatology|September 5, 2002
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoidesX Mao, D Lillington, J J Scarisbrick, et al.
Cancer Genetics and Cytogenetics|January 12, 2005
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromesK Saunders, B Czepulkowski, R Sivalingam, et al.
Oncogene|May 5, 2010
Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycleS J Orr, T Gaymes, D Ladon, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Bone Marrow Transplantation|January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemiaJ Mehta, A Mijović, R Powles, et al.
Journal of Clinical Pathology|June 1, 1987
Unusual myeloid leukaemia in patient with Hodgkin's diseaseM A Horton, M J Barnett, L Goff, et al.
The British Journal of Dermatology|September 5, 2002
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoidesX Mao, D Lillington, J J Scarisbrick, et al.
Cancer Genetics and Cytogenetics|January 12, 2005
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromesK Saunders, B Czepulkowski, R Sivalingam, et al.
Oncogene|May 5, 2010
Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycleS J Orr, T Gaymes, D Ladon, et al.
British Journal of Haematology|January 31, 1998
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemiaJ E Parker, A Pagliuca, A Mijovic, et al.
Pageof 3